This comprehensive program combines cardiovascular risk insights with personalized services, including a baseline risk assessment, guided therapy, continued monitoring, and personal support.

The Metabolic Risk Panel provides a clear path for earlier risk identification,to provide the information you need to help you course-correct earlier.

Leveraging state-of-the-art technology, the ANAlyzeR panel combines multiple tests to screen 25 analyts from a single sample, to enable earlier treatment.

Our high-precision assay, using a simple blood sample, is the same type of assay shown to be as effective as traditional cerebrospinal fluid testing and amyloid positron emission tomography (PET) scans.

IR testing helps with early identification and intervention, which can help reduce or prevent IR progression and reduce the risk for related clinical conditions.